Anorexia nervosa Mental and Behavioural Disorders Anorexia nervosa
Conditions
Interventions
The present study will be a single-center, pilot, randomized, controlled, crossover-group, superiority study to evaluate the feasibility of eight individual sessions of CRT in a specialist inpatient e
Delayed CRT+TAU) within 24 hours of completion of Time 1 assessment. After receiving coded and anonymised data, randomisation will be carried out and managed by a standard statistical package (SPSS/IB
Sponsors
King’s College London (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Participants’ parents/carers/guardians written, informed consent and participants’ informed assent (if below age of 16) informed consent (if above age of 16) 2. Males or females 3. Aged 10-18 4. Diagnosis of AN or atypical AN (according to DSM-V criteria) 5. Newly referred to Rhodes Wood Hospital (Elysium Healthcare) 6. Fluency in English 7. No visual impairment 8. No cognitive impairment 9. No drug or alcohol abuse 10. Absence of severe comorbidity at the time of intake (e.g. psychosis, severe learning disability, brain injury)
Exclusion criteria
Exclusion criteria: 1. No participants’ parents/carers/guardians written, informed consent and no participants’ informed assent (if below age of 16) and no informed consent (if above age of 16) 2. No English language fluency 2. Visual impairment 3. Drug or alcohol abuse 4. Cognitive impairment 5. Severe comorbidity at the time of intake (e.g. psychosis, severe learning disability, brain injury)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Set-shifting (cognitive flexibility), measured with the Wisconsin Card Sorting Task – computerized version (WCST, Heaton et al., 1993) and the Brixton Test at week 1, week 6 and week 11 2. Central coherence, measured with Rey-Osterrieth Complex Figures Task and D-FLEX (Roberts et al., 2011) at week 1, week 6 and week 11 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Intellectual functioning, assessed using Weschler Abbreviated Scale of Intelligence II Two-subtest version (WASI-II 2 subtest) standardised brief assessment of intellectual functioning (IQ) at week 1 2. Eating disorder symptomatology, assessed using Eating Disorder Examination Questionnaire (EDE-Q) standardised self-report measure of eating disorder psychopathology, validated for use in children and adolescents, at week 1, week 6 and week 11 3. Depression, assessed using Revised Child and Anxiety and Depression Scale (R-CADS) standardised self-report measure of anxiety and depression symptoms, validated for use in children and adolescents, at week 1, week 6 and week 11 4. Motivation and confidence to change, assessed using Motivation Ruler self-report measure of importance and confidence to change using Visual Analogue Scale (0-10), created ad hoc, at week 1, week 6 and week 11 5. Autistic spectrum traits, assessed using Social Communications Questionnaire (SCQ-20 item) standardised measure of Autism Spectrum Disorder traits, completed by parents/guardians, at week 1, week 6 and week 11 6. Presence and severity of social impairment within the autism spectrum, assessed using Social Responsiveness Scale (SRS) standardised measure to identify the presence and severity of social impairment within the autism spectrum and differentiates it from that which occurs in other disorders, at week 1, week 6 and week 11 7. Satisfaction with the intervention, assessed using individual satisfaction questionnaire, created ad hoc, self-report measure for completion at end of intervention. This measure will be adapted to include an ‘open feedback’ section, in order to enable participants to expand on their thoughts and feedback about the group CRT intervention. Participants are asked to provide their views regarding: what they found beneficial and what challenging; what they enjoyed and w | — |
Countries
England, United Kingdom
Outcome results
None listed